Pharma Industry News

FDA grants BMS priority review for colorectal cancer combo

The Opdivo and Yervoy combination has been also granted breakthrough therapy designation for this potential indicationOriginal Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]